A less invasive set of options induce a partial lesion of the intracavernous portion of the trigeminal nerve root. The trigeminal nerve is approached percutaneously and the foramen ovale is ...

The objectives of the present study were: to establish the herpetic etiology of the postoperative vesicular facial lesions that appear after trigeminal sensory-root section; to determine by ...

Submission for New Intended Use That Leverages Company’s Patented OneRF® Technology Platform Expected in May 2025 EDEN PRAIRIE, Minn., March 11, ...

NeuroOne (Nasdaq:NMTC) announced today that it priced an underwritten registered public offering of common stock worth $8 million.

Technologies accelerated the anticipated timeline of its 510(k) submission to the FDA for trigeminal nerve ablation to ...